Sanara Ventures

growth-positive

Teva Pharmaceutical Industries Ltd. has announced an investment of $10 million in Sanara Capital, a Health-Tech fund from the Sanara group. This investment aligns with Tevas commitment to innovation and supports its Pivot to Growth strategy. Sanara Capital is a venture capital fund that invests in Israeli startups in the fields of digital health, Bio-Convergence, and medical equipment. The fund was established two years ago and has so far invested in six companies.

growth-positive

Sanara Ventures, a healthcare investment platform backed by Teva Pharmaceutical Industries and Philips Healthcare, is setting up a $100 million venture capital fund to take advantage of opportunities in the healthcare sector caused by the Covid pandemic. The CEO of Sanara Ventures, Assaf Barnea, believes that changing the incentive model across the healthcare system, including technology companies, is key to solving its problems. Sanara Ventures is interested in investing in digital health, data-driven medical equipment, and bioconvergence companies. The fund has already made investments in TailorMed and CVAID Medical. Barnea also emphasizes the importance of cooperation and information sharing among market players in the healthcare sector.

growth-positive

Ichilov Hospital and Sanara Ventures have partnered to collaborate in the field of neurology, with Sanara Ventures investing in the hospitals innovative technologies. The collaboration aims to turn ideas and projects developed in the neurology department into groundbreaking projects in the fields of digital health and neurology. Sanara Ventures will provide holistic and technological assistance to researchers and help guide startups throughout the investment stages. The partnership intends to support early-stage ventures, provide funding, and realize their business and technological potential. Sanara Ventures is an investment platform for innovative startups, backed by the Israeli Innovation Authority and including global giants such as Philips Healthcare and Teva Pharmaceuticals.

growth-positive

Assaf Barnea, CEO of Sanara Ventures, emphasizes the importance of knowledge-sharing and defining a product in the life science sector. Sanara Ventures, backed by Phillips and Teva Pharmaceutical Industries Ltd., supports 16 portfolio companies in the digital health and medical equipment sectors. The COVID-19 pandemic expedited innovation in medicine but also affected investments. Barnea highlights the shift towards telemedicine, remote diagnostics, patient engagement, and AI-powered decision support. Israel, with its numerous medical startups, is well-positioned to benefit from this breakthrough. The Israeli government has invested in digital health, and there is a vibrant investment community for Israeli medtech. Barnea encourages entrepreneurs to precisely define their business models and reduce burn rate. He also emphasizes the negative impact of canceled conferences on knowledge-sharing.

growth-positive

The coronavirus outbreak has accelerated the adoption of digital healthcare and telemedicine, causing a paradigm shift in the mindset of healthcare systems worldwide. Sanara Ventures, a healthcare investment platform, predicts that digital solutions will dramatically change the way care is delivered in the next two to five years globally. The company is seeking investments for its new Sanara Capital fund, which focuses on artificial intelligence-related solutions in medicine. The government of Israel has approved a national digital health plan to accelerate technological development, and approximately 580 digital health companies are operating in Israel. Sanara Ventures is building a catalog of Israeli companies offering solutions related to the crisis, ranging from ventilation machines to remote monitoring and disease management. The companys portfolio company, MyHomeDoc, is nearing US FDA approval for its digital health smartphone add-on that enables primary care tests for patients at home.